Dr Rebecca Kristeleit specialises in the treatment of gynaecological cancers. She also has a specialist interest in drug development as well and is leading several clinical trials of novel agents relevant to gynaecological malignancies including PARP inhibitors.
Rebecca qualified in medicine from St Andrew’s and Manchester Universities including eight months at the University of Lausanne (Switzerland) on an Erasmus scholarship. Following general medical training in London, Rebecca undertook her medical oncology training at The Royal Marsden Hospital and a CRUK-funded research fellowship at the Institute of Cancer Research. Subsequently, Rebecca spent a year as a senior research fellow on the Drug Development Unit at the Royal Marsden Hospital gaining specialist experience in the design and conduct of early phase clinical trials and translational medicine.
Her research work, as part of the UCLH gynaecological oncology team, Clinical Research Facility at UCLH and the UCL Cancer Institute, is focused on the development of early phase clinical trials and translational research to identify and evaluate innovative treatment strategies for gynaecological malignancies as well as other solid tumours.
Consultant Medical OncologistUniversity College London Hospitals NHS Foundation Trust
London W1G 6JA
View map and location details
Main switchboard: +44 (0) 207 935 4444
Treatment enquiries: +44 (0) 207 616 7693Consultant appointments: +44 (0) 207 616 7693 Prices for self funding patients: +44 (0) 203 219 3315Physiotherapy appointments: +44 (0) 207 616 7651X-ray and scan appointments: +44 (0) 207 616 7653Invoice and payment enquiries: +44 (0) 207 616 7708